Roivant Sciences Ltd. (ROIV) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Roivant Sciences Ltd. (ROIV) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $20.91B, listed on NASDAQ, employing roughly 908 people, carrying a beta of 1.14 to the broader market. Roivant Sciences Ltd. Led by Matthew Gline, public since 2020-12-08.
Snapshot as of May 15, 2026.
- Spot Price
- $29.45
- Total OI
- 45.7K